Regulatory aspects for Biologic Product licensing in Australia
Journal Title: International Journal of Drug Regulatory Affairs - Year 2019, Vol 7, Issue 2
Abstract
The TG Act defines biological as product made, from or containing, human cells or human tissues, lives animal organs, cells or tissues, and that is used to treat or prevent disease or injury, Diagnose a condition of a person and Alter the physiological processes of a person. The Australian Regulatory Guidelines for Biologicals (ARGB) provide the keen information for manufacturers, sponsors, professionals in healthcare and also to public about the use of human cells and tissues based therapeutic goods, live animal cells, organs and tissues (1). These all products are Biologicals. This guideline is specially written for general public. If you are a sponsor or manufacture, this will: • Explains the biological regulatory framework is applies to manufacturer’s product and their exemption conditions (1). • Explains the Australian regulatory requirements for supplying of Biologicals • Explains what is required for the market authorization as per TGA especially for Biologicals.
Authors and Affiliations
Sanjeev Kumar Maurya, Vikesh Kumar Shukla, Sunny Kumar Maurya, Prachi Kaushik, Indu Maurya
Keywords
Related Articles
- EP ID EP625605
- DOI 10.22270/ijdra.v7i2.310
- Views 99
- Downloads 0
UNDERSTANDING TECHNICAL BARRIERS TO TRADE AGREEMENT
Signing of formation of World Trade Organization has transformed trade, services and intellectual property into a mutual, predictable exchange of trade and intellectual property protection among member countries. Countri...
Saxagliptin and Dapagliflozin for type 2 Diabetes mellitus: A Review
Qtern® is a fixed dose combination tablet of Saxagliptin and Dapagliflozin which is indicated for the advancement of glycaemic control in adults with type 2 diabetes mellitus (T2DM). It can be done either when medication...
Comparative study of the harmonization of pharmaceutical regulations in the western and central sub-regions of Africa
The harmonization of pharmaceutical regulations in Africa aims to offer States a coherent body of texts and practices by combining limited resources. The objective of this study was to describe policies to harmonize phar...
A PRAGMATIC WAY TO SUSTAIN IN GENERIC PHARMA ENVIRONMENT: PLCM THROUGH REGULATORY STRATEGIES
Most thoughtful way to sustain in this competitive highly regulated Pharma generic industry environment is depended on understanding the concept of the product life cycle management (PLCM). Fact is a very less number of...
Simultaneous estimation of xanthine alkaloids (Theophylline, Theobromine and Caffeine) by High-Performance Liquid Chromatography
Methylxanthines are mainly a group of phytochemicals which are derived from purine base xanthine. These xanthines are obtained from plant as a result of secondary metabolism. There are various physiological actions that...